Additional file 5: of Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia

Table S1. BALF chemokine levels 6 and 21 h after intranasal LTA administration in vehicle and ibrutinib treated mice. (DOC 40 kb)